|
Showing the most relevant articles for your search:AMEX:ILI | 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 | | 2010/08/13 | 05 : 07 | Edgar (US Regulatory) | Quarterly Report (10-Q) | AMEX:ILI | Interleukin Genetics, |
| 2010/08/06 | 05 : 01 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | AMEX:ILI | Interleukin Genetics, |
| 2010/08/05 | 21 : 49 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | AMEX:ILI | Interleukin Genetics, |
| 2010/08/05 | 20 : 02 | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ILI | Interleukin Genetics, |
| 2010/07/22 | 05 : 30 | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ILI | Interleukin Genetics, |
| 2010/06/26 | 06 : 06 | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ILI | Interleukin Genetics, |
| 2010/06/21 | 19 : 31 | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ILI | Interleukin Genetics, |
| 2010/05/14 | 05 : 06 | Edgar (US Regulatory) | Quarterly Report (10-Q) | AMEX:ILI | Interleukin Genetics, |
| 2010/05/05 | 19 : 02 | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | AMEX:ILI | Interleukin Genetics, |
| 2010/05/01 | 08 : 09 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:ILI | Interleukin Genetics, |
| 2010/05/01 | 08 : 06 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | AMEX:ILI | Interleukin Genetics, |
| 2010/05/01 | 05 : 36 | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ILI | Interleukin Genetics, |
| 2010/05/01 | 02 : 15 | Edgar (US Regulatory) | Proxy Statement (definitive) (DEF 14A) | AMEX:ILI | Interleukin Genetics, |
| 2010/04/14 | 06 : 04 | Edgar (US Regulatory) | Amended Statement of Changes in Beneficial Ownership (4/A) | AMEX:ILI | Interleukin Genetics, |
| 2010/04/09 | 05 : 25 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:ILI | Interleukin Genetics, |
| 2010/04/09 | 05 : 24 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:ILI | Interleukin Genetics, |
| 2010/04/06 | 05 : 35 | Edgar (US Regulatory) | Amended Statement of Changes in Beneficial Ownership (4/A) | AMEX:ILI | Interleukin Genetics, |
| 2010/04/02 | 05 : 08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:ILI | Interleukin Genetics, |
| 2010/03/26 | 05 : 13 | Edgar (US Regulatory) | Annual Report (10-K) | AMEX:ILI | Interleukin Genetics, |
| 2010/03/20 | 05 : 21 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:ILI | Interleukin Genetics, |
| 2010/03/11 | 07 : 11 | Edgar (US Regulatory) | Free Writing Prospectus - Filing under Securities Act Rules 163/433 (FWP) | AMEX:ILI | Interleukin Genetics, |
| 2010/03/09 | 23 : 46 | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | AMEX:ILI | Interleukin Genetics, |
| 2010/03/06 | 04 : 52 | Edgar (US Regulatory) | Prospectus filed pursuant to Rule 424(b)(5) (424B5) | AMEX:ILI | Interleukin Genetics, |
| 2010/03/04 | 04 : 04 | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ILI | Interleukin Genetics, |
| 2010/03/02 | 07 : 00 | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ILI | Interleukin Genetics, |
| 2010/02/20 | 07 : 03 | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | AMEX:ILI | Interleukin Genetics, |
| 2010/02/04 | 21 : 00 | PR Newswire (US) | Interleukin Genetics to Present at the 12th Annual BIO CEO Conference | AMEX:ILI | |
| 2010/02/04 | 06 : 34 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | AMEX:ILI | Interleukin Genetics, |
| 2010/02/03 | 07 : 01 | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ILI | Interleukin Genetics, |
| 2010/01/26 | 06 : 17 | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ILI | Interleukin Genetics, |
|
Showing the most relevant articles for your search:AMEX:ILI |
|